Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$6.13M Sell
33,200
-39,400
-54% -$6.97M 0.03% 681
2018
Q1
$12.4M Buy
72,600
+25,600
+54% +$4.7M 0.05% 373
2017
Q4
$8.17M Sell
47,000
-515,000
-92% -$91.1M 0.04% 562
2017
Q3
$105M Sell
562,000
-471,700
-46% -$83.6M 0.53% 20
2017
Q2
$178M Buy
1,033,700
+884,500
+593% +$144M 1.03% 8
2017
Q1
$24.5M Sell
149,200
-3,600
-2% -$598K 0.2% 81
2016
Q4
$22.3M Sell
152,800
-74,500
-33% -$11.2M 0.16% 109
2016
Q3
$37.9M Buy
227,300
+130,500
+135% +$22.1M 0.28% 37
2016
Q2
$14.7M Sell
96,800
-126,900
-57% -$19.7M 0.11% 192
2016
Q1
$33.5M Sell
223,700
-4,600
-2% -$683K 0.27% 43
2015
Q4
$37.1M Sell
228,300
-96,900
-30% -$15.2M 0.25% 45
2015
Q3
$45M Buy
325,200
+279,600
+613% +$44.1M 0.24% 55
2015
Q2
$7M Sell
45,600
-72,200
-61% -$11.6M 0.04% 631
2015
Q1
$18.8M Sell
117,800
-6,300
-5% -$992K 0.14% 132
2014
Q4
$19.8M Sell
124,100
-134,500
-52% -$21M 0.15% 129
2014
Q3
$36.3M Buy
258,600
+233,100
+914% +$30.4M 0.28% 42
2014
Q2
$3.02M Sell
25,500
-204,200
-89% -$23.6M 0.03% 811
2014
Q1
$28.3M Buy
229,700
+202,300
+738% +$24.5M 0.24% 45
2013
Q4
$3.13M Sell
27,400
-323,600
-92% -$36.8M 0.02% 1075
2013
Q3
$19.7M Buy
351,000
+305,100
+665% +$33.1M 0.13% 113
2013
Q2
$4.53K Buy
+45,900
New +$4.76M 0.02% 836

Other funds holding AMGN

PEAK6 Group's AMGN Position: Q2 2018 in Review

PEAK6 Group increased its Amgen (AMGN) stake by 4.5% in Q2 2018, buying an estimated $83K and bringing the position to 10,886 shares worth $2.01M. The position accounts for 0.01% of the portfolio, ranked #1357.

PEAK6 Group first reported a position in AMGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $12.2M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • PEAK6 Group held 10,886 shares of Amgen worth $2.01M as of Q2 2018.
  • PEAK6 Group bought 469 Amgen shares in Q2 2018, an estimated $83K.
  • Amgen made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1357 holding.
  • PEAK6 Group first reported a position in Amgen in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Amgen position peaked at $12.2M in Q3 2016.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.